Follow-up Testing for Curatively Treated Cancer Survivors: What to Do?

JAMA: The Journal of the American Medical Association

Volumn 273, Issue 23, 1995, Pages 1877-1878

  Loprinzi, Charles L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CANCER TEST; EDITORIAL; FOLLOW UP; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0029033026     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1995.03520470085038     Document Type: Article

References (6)

1. Virgo KS, Vernava AM, Longo WE, McKirgan LW, Johnson FE. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA. 1995;273: 1837-1841.
2. GIVIO Invesigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial. JAMA. 1994;271:1587-1592.
3. Del Turco MR, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V. Intensive diagnostic follow-up after treatment of primary breast cancer: a randomized trial. JAMA. 1994;271:1593-1597.
4. Loprinzi CL. It is now the age to define the appropriate follow-up of primary breast cancer patients. J Clin Oncol. 1984;12:881-883.
5. Weiss, M, Loprinzi CL, Creagan ET, Dalton RJ, O’Fallon JR, Novotny P. Utility of follow-up tests for detecting disease recurrence of surgically resected primary malignant melanoma. In: Proceedings of the annual meeting of the American Society of Clinical Oncology; March 1995; Los Angeles, Calif. Abstract 893.
6. Browman GP, Levine MN, Mohide EA, et al. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol. 1995;13:502-512.